7 June 2022: In the ever-evolving landscape of healthcare, technology is spearheading a remarkable revolution in patient recruitment for clinical trials, empowering researchers and transforming the way participants are identified, engaged, and enrolled. Evrima Technologies, led by Chief Technology Officer and Board Director Ben McEvoy, stands at the forefront of this transformation, leveraging the power of technology to disrupt the clinical trial recruitment process and alleviate common challenges and misconceptions.
“The power of technology lies in its ability to connect, inform, and empower. I’m determined to leverage this power to transform the clinical trial recruitment process,” says Ben McEvoy. “By embracing innovation and dispelling misconceptions, we can create a future where clinical trials are seen as opportunities, not obstacles, and where patients are partners in research.”
Evrima Technologies is renowned for its advanced technology within the industry, offering a time-saving solution for clinical trial recruitment that has already been widely adopted in sites around Australia. Their innovative technology is specifically designed to connect researchers, clinicians, and patients, accelerating research and bringing new treatments to those in need.
Ben McEvoy outlines his four-step approach to optimise Evrima’s clinical trial recruitment process:
- Find: The company reaches potential participants through digital channels, including healthcare provider platforms.
- Match: Evrima employs a comprehensive process to help prospective participants determine their suitability and willingness to join a clinical trial.
- Enroll: Through close relationships with clinical trial sites and prospective participants, Evrima facilitates effective, highly qualified referrals.
- Retain: Evrima leverages technology to create a comfortable trial experience for participants, even enabling remote participation from the comfort of their own homes. Retention is crucial, as replacing a participant after dropout costs twice as much.
While Ben acknowledges that advanced technology can streamline and optimise the recruitment process, he emphasises that human connection remains paramount in establishing trust, building rapport, and addressing the unique needs of potential participants. “Personal interactions and effective communication are key factors in engaging individuals and encouraging their active participation in clinical trials. Technology alone won’t solve the entire problem. It should be seen as a tool to enhance and support a person in their health journey,” states McEvoy. “By combining the power of technology with empathetic human interactions, clinical trial recruitment efforts can be more effective in reaching diverse populations, addressing apprehension, and fostering meaningful engagement. Recognising the importance of human connection alongside technological advancements ensures a participant-centric approach that considers the emotional and psychological aspects of individuals involved in clinical trials.”
Evrima Technologies has experienced significant growth and expansion since February 2021, achieving remarkable milestones, including:
- A 43.5% increase in team size, reflecting the company’s commitment to innovation and excellence.
- Securing contracts with leading bio-pharmaceutical clients, who have continued to choose Evrima as their trusted partner.
- Recognition as the #29 company in the AFR 2022 Fast 100 Starters, showcasing their rapid growth and impact.
- Ranked #8 in Deloitte’s Tech Fast 50 Australia 2021: Rising Star award, highlighting their position as a rising star in the tech industry.
- Ranked #9 in Deloitte’s Tech Fast 50 Australia 2021: Female Leadership award, recognising Evrima’s dedication to promoting diversity and empowering women in leadership roles.
Evrima Technologies remains committed to driving advancements in clinical trial recruitment, leveraging technology and human connection to shape a future where participants are active partners in research. Their ground-breaking approach continues to revolutionise the industry, ultimately benefiting patients and advancing healthcare on a global scale. To learn more about Evrima Technologies, visit here: https://evrima.com/
